Cure pharmaceutical's® wholly owned subsidiary seralabs® introduces nutri-strips™, a revolutionary oral thin film strip technology

Los angeles & oxnard, calif.--(business wire)--cure pharmaceutical holding (otcqb: curr) wholly owned subsidiary sera labs is challenging the status quo of the health and wellness sector by bringing innovative products to market using groundbreaking technology and superior ingredients. as a trusted industry leader that continues to offer consumer solutions, sera lab's is launching the nutri-strips brand with a multi-channel advertising and marketing strategy beginning initially with “sleep a.s.
CURR Ratings Summary
CURR Quant Ranking